BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8353288)

  • 1. Tyrosine phosphorylation of P160 BCR by P210 BCR-ABL.
    Lu D; Liu J; Campbell M; Guo JQ; Heisterkamp N; Groffen J; Canaani E; Arlinghaus R
    Blood; 1993 Aug; 82(4):1257-63. PubMed ID: 8353288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon.
    Liu J; Campbell M; Guo JQ; Lu D; Xian YM; Andersson BS; Arlinghaus RB
    Oncogene; 1993 Jan; 8(1):101-9. PubMed ID: 8423987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
    Campbell ML; Li W; Arlinghaus RB
    Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells.
    Mandanas RA; Leibowitz DS; Gharehbaghi K; Tauchi T; Burgess GS; Miyazawa K; Jayaram HN; Boswell HS
    Blood; 1993 Sep; 82(6):1838-47. PubMed ID: 7691239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phosphorylation of p160 BCR within p210 BCR-ABL complexes during early stages of phorbol ester-induced differentiation of K562 cells.
    Campbell ML; Lu D; Guo JQ; Arlinghaus RB
    Cell Growth Differ; 1993 Jul; 4(7):581-8. PubMed ID: 8398898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo.
    LaMontagne KR; Flint AJ; Franza BR; Pandergast AM; Tonks NK
    Mol Cell Biol; 1998 May; 18(5):2965-75. PubMed ID: 9566916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
    Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
    Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members.
    Ilaria RL; Van Etten RA
    J Biol Chem; 1996 Dec; 271(49):31704-10. PubMed ID: 8940193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family.
    Reuther GW; Fu H; Cripe LD; Collier RJ; Pendergast AM
    Science; 1994 Oct; 266(5182):129-33. PubMed ID: 7939633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.
    McWhirter JR; Wang JY
    Mol Cell Biol; 1991 Mar; 11(3):1553-65. PubMed ID: 1705008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
    Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
    Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias.
    McWhirter JR; Wang JY
    EMBO J; 1993 Apr; 12(4):1533-46. PubMed ID: 8467803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation.
    Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB
    Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.
    Muller AJ; Young JC; Pendergast AM; Pondel M; Landau NR; Littman DR; Witte ON
    Mol Cell Biol; 1991 Apr; 11(4):1785-92. PubMed ID: 2005881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.
    Pendergast AM; Gishizky ML; Havlik MH; Witte ON
    Mol Cell Biol; 1993 Mar; 13(3):1728-36. PubMed ID: 8441409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two normal bcr gene products in the cytoplasm.
    Dhut S; Dorey EL; Horton MA; Ganesan TS; Young BD
    Oncogene; 1988 Nov; 3(5):561-6. PubMed ID: 3078961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein.
    Liu J; Wu Y; Arlinghaus RB
    Cancer Res; 1996 Nov; 56(22):5120-4. PubMed ID: 8912843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcr: a negative regulator of the Bcr-Abl oncoprotein.
    Wu Y; Ma G; Lu D; Lin F; Xu HJ; Liu J; Arlinghaus RB
    Oncogene; 1999 Aug; 18(31):4416-24. PubMed ID: 10442632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
    Carlesso N; Frank DA; Griffin JD
    J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia.
    Melo JV; Gordon DE; Tuszynski A; Dhut S; Young BD; Goldman JM
    Blood; 1993 May; 81(10):2488-91. PubMed ID: 8490164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.